Overactive mTOR and its resistance to insulin stimulation are considered pathological features of AD that represent insulin resistance independent of type-2 diabetes (Oddo, 2012; Norambuena et al., 2017), along with impaired insulin receptor function in AD postmortem brain (Talbot et al., 2012). The gene discussed is INS; the disease is Alzheimer disease.